Solid tumor

BeiGene is advancing a solid tumor pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. Among these are tislelizumab, a monoclonal antibody against PD-1 and ociperlimap, a monoclonal antibody against TIGIT.
Alla typer
Alla typer
Reading
4
Slide-Kit
6
Video
5
Senaste
Senaste
latest
Äldst
oldest
Alla typer
Alla typer
Reading
4
Slide-Kit
6
Video
5
Senaste
Senaste
latest
Äldst
oldest
Föreslaget:
CLL
EHA
ESMO
Hematologic malignancies
Solid tumor
WM
BeiGene
BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to fight cancer. Get up to date with the BeiGene solid tumor pipeline and clinical trials.
Reading
22 maj 2023
memo
A summary of the latest developments from 12 studies in the treatment of NSCLC, gastric cancers and other solid tumors presented at ESMO 2022.
Slide-Kit
24 okt 2022
Ladda fler

Chatta med BeiGene

Stäng